| Literature DB >> 27688483 |
Adam Gesing1,2,3, Denise Wiesenborn1,4,5, Andrew Do1,6, Vinal Menon1,7, Augusto Schneider1,8, Berta Victoria1, Michael B Stout9, John J Kopchick10, Andrzej Bartke2, Michal M Masternak1,11.
Abstract
Disruption of the growth hormone (GH) signaling pathway promotes insulin sensitivity and is associated with both delayed aging and extended longevity. Two kinds of long-lived mice-Ames dwarfs (df/df) and GH receptor gene-disrupted knockouts (GHRKO) are characterized by a suppressed GH axis with a significant reduction of body size and decreased plasma insulin-like growth factor-1 (IGF-1) and insulin levels. Ames dwarf mice are deficient in GH, prolactin, and thyrotropin, whereas GHRKOs are GH resistant and are dwarf with decreased circulating IGF-1 and increased GH. Crossing Ames dwarfs and GHRKOs produced a new mouse line (df/KO), lacking both GH and GH receptor. These mice are characterized by improved glucose tolerance and increased adiponectin level, which could imply that these mice should be also characterized by additional life-span extension when comparing with GHRKOs and Ames dwarfs. Importantly, our longevity experiments showed that df/KO mice maintain extended longevity when comparing with N control mice; however, they do not live longer than GHRKO and Ames df/df mice. These important findings indicate that silencing GH signal is important to extend the life span; however, further decrease of body size in mice with already inhibited GH signal does not extend the life span regardless of improved some health-span markers.Entities:
Keywords: Ames dwarf mice; Dwarfism; GHRKO mice; Insulin signaling; Longevity
Mesh:
Substances:
Year: 2017 PMID: 27688483 PMCID: PMC5861925 DOI: 10.1093/gerona/glw193
Source DB: PubMed Journal: J Gerontol A Biol Sci Med Sci ISSN: 1079-5006 Impact factor: 6.053